Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

The connective tissue changes of Crohn's disease.

Shelley-Fraser G, Borley NR, Warren BF, Shepherd NA.

Histopathology. 2012 Jun;60(7):1034-44. doi: 10.1111/j.1365-2559.2011.03911.x. Review.

PMID:
22008086
2.

Obesity, visceral fat and Crohn's disease.

Bertin B, Desreumaux P, Dubuquoy L.

Curr Opin Clin Nutr Metab Care. 2010 Sep;13(5):574-80. doi: 10.1097/MCO.0b013e32833cf0f4. Review.

PMID:
20625283
3.

Role of fat and adipokines in intestinal inflammation.

Kredel L, Batra A, Siegmund B.

Curr Opin Gastroenterol. 2014 Nov;30(6):559-65. doi: 10.1097/MOG.0000000000000116. Review.

PMID:
25188546
4.

Long-term changes in adipose tissue in human disease.

Pond CM.

Proc Nutr Soc. 2001 Aug;60(3):365-74. Review.

PMID:
11681811
5.

Concepts of oxidative stress and antioxidant defense in Crohn's disease.

Alzoghaibi MA.

World J Gastroenterol. 2013 Oct 21;19(39):6540-7. doi: 10.3748/wjg.v19.i39.6540. Review.

6.

Pathogenesis and therapeutic aspects of Crohn's disease.

Selby W.

Vet Microbiol. 2000 Dec 20;77(3-4):505-11. Review.

PMID:
11118735
7.

Contribution of morphology for the comprehension of mechanisms of fibrosis in inflammatory enterocolitis.

Geboes KP, Cabooter L, Geboes K.

Acta Gastroenterol Belg. 2000 Oct-Dec;63(4):371-6. Review.

PMID:
11233520
8.

MRI in Crohn's disease--current and future clinical applications.

Fiorino G, Bonifacio C, Malesci A, Balzarini L, Danese S.

Nat Rev Gastroenterol Hepatol. 2011 Nov 22;9(1):23-31. doi: 10.1038/nrgastro.2011.214. Review.

PMID:
22105109
9.

Inflammatory bowel disease: the surgical pathology of Crohn's disease and ulcerative colitis.

Price AB, Morson BC.

Hum Pathol. 1975 Jan;6(1):7-29. Review.

PMID:
1089084
10.

Diagnostic problems and advances in inflammatory bowel disease.

Odze R.

Mod Pathol. 2003 Apr;16(4):347-58. Review.

11.

Pathogenic aspects and therapeutic avenues of intestinal fibrosis in Crohn's disease.

Zorzi F, Calabrese E, Monteleone G.

Clin Sci (Lond). 2015 Dec;129(12):1107-13. doi: 10.1042/CS20150472. Review.

PMID:
26494636
12.
13.

Circulating fibrocytes and Crohn's disease.

Sahebally SM, Burke JP, Chang KH, Kiernan MG, O'Connell PR, Coffey JC.

Br J Surg. 2013 Nov;100(12):1549-56. doi: 10.1002/bjs.9302. Review.

PMID:
24264775
14.

Adipose-tissue and intestinal inflammation - visceral obesity and creeping fat.

Kredel LI, Siegmund B.

Front Immunol. 2014 Sep 24;5:462. doi: 10.3389/fimmu.2014.00462. Review.

15.

Retroperitoneal, mesenteric and multifocal fibrosis: review of their aetiopathogenesis. A possible role of adipocytes as in Crohn's disease?

Jacobs E, Cosyns JP, Fiasse R.

Acta Gastroenterol Belg. 2010 Apr-Jun;73(2):252-60. Review.

PMID:
20690565
16.

Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?

Peyrin-Biroulet L, Chamaillard M, Gonzalez F, Beclin E, Decourcelle C, Antunes L, Gay J, Neut C, Colombel JF, Desreumaux P.

Gut. 2007 Apr;56(4):577-83. Review. No abstract available.

17.

Neuropeptides, mesenteric fat, and intestinal inflammation.

Karagiannides I, Pothoulakis C.

Ann N Y Acad Sci. 2008 Nov;1144:127-35. doi: 10.1196/annals.1418.009. Review.

18.

Bacterial translocation - impact on the adipocyte compartment.

Kruis T, Batra A, Siegmund B.

Front Immunol. 2014 Jan 6;4:510. doi: 10.3389/fimmu.2013.00510. Review.

19.

Intestinal fibrosis in Crohn's disease: role of microRNAs as fibrogenic modulators, serum biomarkers, and therapeutic targets.

Lewis A, Nijhuis A, Mehta S, Kumagai T, Feakins R, Lindsay JO, Silver A.

Inflamm Bowel Dis. 2015 May;21(5):1141-50. doi: 10.1097/MIB.0000000000000298. Review.

PMID:
25636122
20.

The "creeping fat sign"-really diagnostic for Crohn's disease?

Golder WA.

Int J Colorectal Dis. 2009 Jan;24(1):1-4. doi: 10.1007/s00384-008-0585-y. Review.

PMID:
18815796
Items per page

Supplemental Content

Support Center